Microbiology & Infectious Diseases

A landmark trial combining novel therapies has produced the first signs of durable post-treatment HIV control, pointing to a new frontier in functional cure research.

Prior dengue infection reshapes innate immunity, boosting vaccine efficacy. Vaccination alone fails to replicate these immune changes.

Global disparities in AMR governance show high-income countries with stronger plans, while low-income nations face weaker strategies and higher infection burdens.

A 3-month clofazimine- and rifapentine-containing regimen for drug-susceptible TB failed to improve cure rates and caused more severe adverse events than standard therapy, according to the Clo-Fast trial.

New UKHSA data show pre-school booster coverage has fallen to 81.4% in England, below herd immunity thresholds, leaving children vulnerable to outbreaks.

Discover how machine learning shows high accuracy for HIV prediction but needs better validation before use in STI clinical practice.

Three monoclonal antibodies targeting monkeypox A35 protein protect mice and improve outcomes, highlighting potential for new therapies.

A new study suggests that the common cold may boost children’s antiviral defences, lowering the risk and severity of COVID-19.